Frataxin Silencing Inactivates Mitochondrial Complex I in NSC34 Motoneuronal Cells and Alters Glutathione Homeostasis

International Journal of Molecular Sciences

Barbara Carletti³  Emanuela Piermarini³  Giulia Tozzi³  Lorena Travaglini³  Alessandra Torraco³  Anna Pastore²  Marco Sparaco¹  Sara Petrillo³  Rosalba Carrozzo³  Enrico Bertini³ 

[1] Division of Neurology, Department of Neurosciences, Azienda Ospedaliera, “G. Rummo”, Via Pacevecchia 53, 82100 Benevento, Italy; E-Mail:;Biochemistry Laboratory, Children’s Hospital and Research Institute “Bambino Gesù”, Piazza S. Onofrio 4, 00165 Rome, Italy; E-Mail:;Unit for Neuromuscular and Neurodegenerative Diseases, Children’s Hospital and Research Institute “Bambino Gesù”, Piazza S. Onofrio 4, 00165 Rome, Italy; E-Mails:

关键词: Friedreich’s ataxia;    neurodegeneration;    glutathione;    oxidative stress;    mitochondrial enzymes;   

DOI  :  10.3390/ijms15045789

来源: mdpi

【 摘 要 】

Friedreich’s ataxia (FRDA) is a hereditary neurodegenerative disease characterized by a reduced synthesis of the mitochondrial iron chaperon protein frataxin as a result of a large GAA triplet-repeat expansion within the first intron of the frataxin gene. Despite neurodegeneration being the prominent feature of this pathology involving both the central and the peripheral nervous system, information on the impact of frataxin deficiency in neurons is scant. Here, we describe a neuronal model displaying some major biochemical and morphological features of FRDA. By silencing the mouse NSC34 motor neurons for the frataxin gene with shRNA lentiviral vectors, we generated two cell lines with 40% and 70% residual amounts of frataxin, respectively. Frataxin-deficient cells showed a specific inhibition of mitochondrial Complex I (CI) activity already at 70% residual frataxin levels, whereas the glutathione imbalance progressively increased after silencing. These biochemical defects were associated with the inhibition of cell proliferation and morphological changes at the axonal compartment, both depending on the frataxin amount. Interestingly, at 70% residual frataxin levels, the in vivo treatment with the reduced glutathione revealed a partial rescue of cell proliferation. Thus, NSC34 frataxin silenced cells could be a suitable model to study the effect of frataxin deficiency in neurons and highlight glutathione as a potential beneficial therapeutic target for FRDA.

【 授权许可】

CC BY   
© 2014 by the authors; licensee MDPI, Basel, Switzerland